Stock analysis Medicamen Biotech Limited MEDICAMEQ
More indepth analysis on MunafaSutra.com
Recent prices of MEDICAMEQ Medicamen Biotech Limited are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
30 Fri May 2025 | 428.20 | 426.75 to 444.95 | -0.06% | 2.45 times |
29 Thu May 2025 | 428.45 | 424.95 to 440.40 | -0.95% | 0.99 times |
28 Wed May 2025 | 432.55 | 430.30 to 437.40 | 0.73% | 0.96 times |
27 Tue May 2025 | 429.40 | 428.80 to 438.95 | -0.41% | 0.77 times |
26 Mon May 2025 | 431.15 | 428.80 to 440.15 | 0.37% | 0.65 times |
23 Fri May 2025 | 429.55 | 426.60 to 440.00 | -0.08% | 1.24 times |
22 Thu May 2025 | 429.90 | 426.60 to 439.45 | -0.49% | 0.91 times |
21 Wed May 2025 | 432.00 | 429.90 to 442.40 | -1.18% | 0.97 times |
20 Tue May 2025 | 437.15 | 433.00 to 455.95 | -1.52% | 0.82 times |
19 Mon May 2025 | 443.90 | 441.00 to 454.70 | -1.41% | 1.75 times |
16 Fri May 2025 | 450.25 | 447.10 to 454.50 | 0.09% | 0.93 times |
15 Thu May 2025 | 449.85 | 440.05 to 454.50 | 1.48% | 1.63 times |
Technical analysis forecast for Medicamen Biotech Limited Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Medicamen Biotech Limited MEDICAMEQ at this time. Stock is falling and might fall more.
It appears as if Medicamen Biotech Limited MEDICAMEQ gave a large move recently.
Stock of Medicamen Biotech Limited (MEDICAMEQ) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...
My analysis of Medicamen Biotech Limited is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Medicamen Biotech Limited stays below 428.4, but if it comes above 428.4, then a intra day buy could be more profitable.
If you take a sell trade below 428.4, then use 428.4 as stoploss and 418.3 as target. However if you take a buy trade in Medicamen Biotech Limited, then use 428.4 as stoploss and 436.8 as target.